SkinHealth Systems (SKIN) Cash & Current Investments (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Cash & Current Investments data on file, last reported at $204.4 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $204.4 million, down 45.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $204.4 million (down 45.22% YoY), and the FY2025 annual result was $232.7 million, down 37.13% from the prior year.
• Cash & Current Investments fell to $204.4 million in Q1 2026 per SKIN's latest filing, from $232.7 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $859.2 million in Q1 2022 and troughed at $204.4 million in Q1 2026.
• A 5-year average of $462.5 million and a median of $444.6 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2026: Cash & Current Investments surged 31109.19% in 2022, then plunged 45.22% in 2026.
• A 5-year view of Cash & Current Investments shows it stood at $568.2 million in 2022, then fell by 7.95% to $523.0 million in 2023, then slipped by 29.25% to $370.1 million in 2024, then slumped by 37.13% to $232.7 million in 2025, then retreated by 12.17% to $204.4 million in 2026.
• Business Quant data shows SKIN's Cash & Current Investments at $204.4 million in Q1 2026, $232.7 million in Q4 2025, and $219.4 million in Q3 2025.